Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size. https://www.sciencedaily.com/releases/2022/04/220430113708.htm
Breakthrough in treatment for Dupuytren’s disease
Artificial Intelligence
April 30, 2022
